RSS-Feed abonnieren
DOI: 10.1055/s-0042-111521
Protective Effects of Puerarin against Aβ 1–42-Induced Learning and Memory Impairments in Mice
Publikationsverlauf
received 13. April 2016
revised 17. Juni 2016
accepted 27. Juni 2016
Publikationsdatum:
15. Juli 2016 (online)
![](https://www.thieme-connect.de/media/plantamedica/20170304/lookinside/thumbnails/10-1055-s-0042-111521_pma0326-1.jpg)
Abstract
Puerarin is a major isoflavone glycoside from the root of Pueraria lobata. It has been reported that puerarin can protect neurons from oxidative stress-induced apoptosis. Emerging evidence suggests that oxidative damage is associated with Aβ-induced neuronal death. In the current study, we evaluated the effect of puerarin on Alzheimerʼs disease induced by Aβ and explored the potential mechanisms underlying this effect. We found that the escape latency of the Morris water maze was decreased in groups treated with puerarin compared to the model group (p < 0.01). In addition, there were significant differences between treated groups and the model group mice in a Y-maze test (p < 0.01). Furthermore, puerarin recovered the levels of brain-derived neurotrophic factor, phosphorylated tau, malondialdehyde, acetylcholine esterase, glycogen synthase kinase-3beta, and the activity of superoxide dismutase to some extent in the hippocampus and cerebral cortex. Shrinkage of nuclei and swollen and eccentrically dispersed neuronal bodies were observed in the hippocampus of Aβ-treated mice. These data demonstrate that puerarin might protect against cognitive deficits, oxidative stress, and neurodegeneration induced by Aβ 1–42.
Key words
puerarin - Pueraria lobata - Fabaceae - Aβ 1–42 - Alzheimerʼs disease - cognitive impairment-
References
- 1 Xie S, Chen J, Li X, Su T, Wang Y, Wang Z, Huang L. Synthesis and evaluation of selegiline derivatives as monoamine oxidase inhibitor, antioxidant and metal chelator against Alzheimerʼs disease. Bioorg Med Chem 2015; 23: 3722-3729
- 2 Banji OJF, Banji D, Ch K. Curcumin and hesperidin improve cognition by suppressing mitochondrial dysfunction and apoptosis induced by D-galactose in rat brain. Food Chem Toxicol 2014; 74: 51-59
- 3 Rottkamp CA, Raina AK, Zhu X, Gaier E, Bush AI, Atwood CS, Chevion M, Perry G, Smith MA. Redox-active iron mediates amyloid-beta toxicity. Free Radic Bio Med 2001; 30: 447-450
- 4 Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007; 8: 57-69
- 5 Uttara B, Singh AV, Zamboni P, Mahajan RT. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol 2009; 7: 65-74
- 6 Wang DM, Liu L, Zhu XY, Wu WL, Wang Y. Hesperidin alleviates cognitive impairment, mitochondrial dysfunction and oxidative stress in a mouse model of Alzheimerʼs disease. Cell Mol Neurobiol 2014; 34: 1209-1221
- 7 Xia CY, Dong XW, Zhao Y, Xu Y, Hao L, Zhang ZX. Ginkgo biloba extract 50 inhibited beta-amyloid-induced oxidative stress in ratsʼ hippocampal neurons: an experimental study. Zhongguo Zhong Xi Yi Jie He Za Zhi 2014; 34: 833-838
- 8 Huh E, Kim HG, Park H, Kang MS, Lee B, Oh MS. Houttuynia cordata improves cognitive deficits in cholinergic dysfunction Alzheimerʼs disease-like models. Biomol Ther (Seoul) 2014; 22: 176-183
- 9 Levi-Montalcini R. The nerve growth factor: its mode of action on sensory and sympathetic nerve cells. Harvey Lect 1966; 60: 217-259
- 10 Choi SM, Kim BC, Cho YH, Choi KH, Chang J, Park MS. Effects of flavonoid compounds on beta-amyloid-peptide-induced neuronal death in cultured mouse cortical neurons. Chonnam Med J 2014; 50: 45-51
- 11 Flaherty DB, Soria JP, Tomasiewicz HG, Wood JG. Phosphorylation of human tau protein by microtubule-associated kinases: GSK3β and cdk5 are key participants. J Neurosci Res 2000; 62: 463-472
- 12 Dajani R, Fraser E, Roe SM, Young N, Good V, Dale TC, Pearl LH. Crystal structure of glycogen synthase kinase 3β: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell 2001; 105: 721-732
- 13 Fahnestock M. Brain-derived neurotrophic factor: the link between amyloid-β and memory loss. Future Neurol 2011; 6: 627-639
- 14 Chueh FS, Chang CP, Chio CC, Lin MT. Puerarin acts through brain serotonergic mechanisms to induce thermal effects. J Pharmacol Sci 2004; 96: 420-427
- 15 Chung MJ, Sung NJ, Park CS, Kweon DK, Mantovani A, Moon TW, Lee SJ. Antioxidative and hypocholesterolemic activities of water-soluble puerarin glycosides in Hepg2 cells and in C57 B1/6j mice. Eur J Pharmacol 2008; 578: 159-170
- 16 Liu Z, Zhao X, Liu B, Liu AJ, Li H, Mao X, Wu B, Bi KS, Jia Y. Jujuboside A, a neuroprotective agent from semen Ziziphi Spinosae ameliorates behavioral disorders of the dementia mouse model induced by Aβ 1–42. Eur J Pharmacol 2014; 738: 206-213
- 17 Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimerʼs disease: progress and problems on the road to therapeutics. Science 2002; 297: 353-356
- 18 Lu XL, Liu JX, Wu Q, Long SM, Zheng MY, Yao XL, Ren H, Wang YG, Su WW, Fai Cheung RT, Zeng JS, Su H, Pei Z. Protective effects of puerarin against Aβ40-induced vascular dysfunction in zebrafish and human endothelial cells. Eur J Pharmacol 2014; 732: 76-85
- 19 Brawn K, Fridovich I. Superoxide radical and superoxide dismutases: threat and defense. Acta Physiol Scand 1980; 492: 9-18
- 20 Zhang X, Xiong J, Liu S, Wang L, Huang J, Liu L, Yang J, Zhang G, Guo K, Zhang Z, Wu P, Wang D, Lin Z, Xiong N, Wang T. Puerarin protects dopaminergic neurons in Parkinsonʼs disease models. Neuroscience 2014; 280: 88-98
- 21 Baptista FI, Henriques AG, Silva AMS, Wiltfang J, Slva O. Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimerʼs disease. ACS Chem Neurosci 2014; 5: 83-92
- 22 Slater TF. Overview of methods used for detecting lipid peroxidation. Methods Enzymol 1984; 105: 283-293
- 23 Elahi M, Motoi Y, Matsumoto SE, Hasan Z, Ishiguro K, Hattori N. Short-term treadmill exercise increased tau insolubility and neuroinflammation in tauopathy model mice. Neurosci Lett 2016; 610: 207-212
- 24 Drechsel DN, Hyman AA, Cobb MH, Kirschner MW. Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. Mol Biol Cell 1992; 3: 1141-1154
- 25 Iqbal K, Alonso ADC, Chen S, Chohan MO, El-Akkad E, Gong CX. Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta 2005; 1739: 198-210
- 26 Uchida K, Shiraishi M, Naito Y, Torii Y, Nakamura Y, Osawa T. Activation of stress signaling intracellular peroxide production. J Biol Chem 1999; 274: 2234-2242
- 27 Li CC, Pan Z, Xu TJ, Zhang C, Wu Q, Niu YC. Puerarin induces the upregulation of glutathione levels and nuclear translocation of Nrf2 through PI3K/Akt/GSK-3β signaling events in PC12 cells exposed to lead. Neurotoxicol Teratol 2014; 46: 1-9
- 28 Qu Z, Zhang J, Yang H, Huo L, Gao J, Chen H, Gao WY. Protective effect of tetrahydropalmatine against d-galactose induced memory impairment in rat. Physiol Behav 2016; 154: 114-125
- 29 Numakawa T, Suzuki S, Kumamaru E, Adachi N, Richards M, Kunugi H. BDNF function and intracellular signaling in neurons. Histol Histopathol 2010; 25: 237-258
- 30 Levi-Montalcini R. The nerve growth factor: its mode of action on sensory and sympathetic nerve cells. Harvey Lect 1966; 60: 217-259
- 31 Li J, Wang G, Liu J, Zhou L, Dong M, Wang R, Li XY, Lin CR, Niu YC. Puerarin attenuates amyloid-beta-induced cognitive impairment through suppression of apoptosis in rat hippocampus in vivo . Eur J Pharmacol 2010; 649: 195-201
- 32 Silveyra MX, Garcia-Ayllon MS, de Barreda EG, Small DH, Martinez S, Avila J. Altered expression of brain acetylcholinesterase in FTDP-17 human tau transgenic mice. Neurobiol Aging 2012; 33: 12
- 33 Craig LA, Hong NS, McDonald RJ. Revisiting the cholinergic in the development of Alzheimerʼs disease. Neurosci Biobehav Rev 2011; 35: 1397-1409
- 34 Song JH, Yu JT, Tan L. Brain-derived neurotrophic factor in Alzheimerʼs disease: risk, mechanisms, and therapy. Mol Neurobiol 2015; 52: 1477-1493
- 35 Li QS, Yang W, Pan YF, Min J, Zhang Z, Gao HZ. Brain-derived neurotrophic factor prevents against amyloid beta protein-induced impairment of hippocampal in vivo long-term potentiation in rats. Zhongguo Zhong Xi Yi Jie He Za Zhi 2012; 28: 425-429
- 36 Sharma M, Gupta YK. Effect of chronic treatment of melatonin on learning, memory and oxidative deficiencies induced by intracerebroventricular streptozotocin in rats. Pharmacol Biochem Behav 2001; 70: 325-331
- 37 Kim DH, Jeon SJ, Son KH, Jung JW, Lee S, Yoon BH, Lee JJ, Cho YW, Cheong JH, Ko KH, Ryu JH. The ameliorating effect of oroxylin A on scopolamine-induced memory impairment in mice. Neurobiol Learn Mem 2007; 87: 536-546
- 38 Mutlu O, Akar F, Celikyurt IK, Tanyeri P, Ulak G, Erden F. 7-NI and ODQ disturbs memory in the elevated plus maze, Morris water maze, and radial arm maze tests in mice. Drug Target Insights 2015; 9: 1-8
- 39 Ahmad M, Saleem S, Ahmad AS, Yousuf S, Ansari MA, Khan MB. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemimac evidences. J Neurochem 2005; 93: 94-104